Timing of hormone therapy and dementia: The critical window theory revisited

Annals of Neurology

Volumn 69, Issue 1, 2011, Pages 163-169

  Whitmer, Rachel A ^a   Quesenberry Jr , Charles P ^a   Zhou, Jufen ^a   Yaffe, Kristine ^b,c  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HORMONE; ORAL ANTIDIABETIC AGENT; PROGESTERONE;

ADULT; AGE DISTRIBUTION; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; DRUG SAFETY; DRUG USE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH SURVEY; HORMONAL THERAPY; HOSPITAL PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY; NEGRO; NEUROPROTECTION; OUTPATIENT; PATIENT INFORMATION; PHARMACY; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; RACE; RISK;

AGE DISTRIBUTION; AGE FACTORS; AGED; CALIFORNIA; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; DEMENTIA; DRUG ADMINISTRATION SCHEDULE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSURANCE, HEALTH; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIPHASIC SCREENING; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 79551493889     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22239     Document Type: Article

References (24)

1. Yaffe K, Sawaya G, Lieberburg I, Grady D., Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279: 688-695.
2. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-2958.
3. Grady D, Yaffe K, Kristof M, et al. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med 2002; 113: 543-548.
4. Resnick SM, Maki PM, Rapp SR, et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 2006; 91: 1802-1810.
5. Sherwin BB., Estrogen and memory in women: how can we reconcile the findings? Horm Behav 2005; 47: 371-375.
6. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002; 288: 2123-2129.
7. Sherwin BB., The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol 2007; 19: 77-81.
8. Bernardi F, Pluchino N, Stomati M, et al. CNS: sex steroids and SERMs. Ann N Y Acad Sci 2003; 997: 378-388.
9. Gibbs RB., Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann N Y Acad Sci 1994; 743: 165-196.
10. McEwen BS, Alves SE, Bulloch K, Weiland NG., Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997; 48 (5 suppl 7): S8-S15.
11. McEwen BS, Gould E, Orchinik M, et al. Oestrogens and the structural and functional plasticity of neurons: implications for memory, ageing and neurodegenerative processes. Ciba Found Symp 1995; 191: 52-66.
12. den Tonkelaar I, Oddens BJ., Determinants of long-term hormone replacement therapy and reasons for early discontinuation. Obstet Gynecol 2000; 95: 507-512.
13. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651-2662.
14. Henderson VW, Benke KS, Green RC, et al. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005; 76: 103-105.
15. Petitti DB, Crooks VC, Chiu V, et al. Incidence of dementia in long-term hormone users. Am J Epidemiol 2008; 167: 692-700.
16. Krieger N., Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992; 82: 703-710.
17. Collen M, Rubin L, Neyman J, et al. Automated multiphasic screening and diagnosis. Am J Public Health 1964; 54: 741-750.
18. Selby JV, Ray GT, Zhang D, Colby CJ., Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997; 20: 1396-1402.
19. Selby JV, Karter AJ, Ackerson LM, et al. Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care 2001; 24: 1547-1555.
20. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001; 111: 1-9.
21. Resnick SM, Maki PM., Effects of hormone replacement therapy on cognitive and brain aging. Ann N Y Acad Sci 2001; 949: 203-214.
22. Sherwin BB., The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol 2007; 19: 77-81.
23. Whitmer RA, Gunderson EP, Barrett-Connor E, et al. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005; 330: 1360.
24. Henderson VW., Estrogen therapy and the brain. In:, Kelsey J, Marcus R, Lobo RA, eds. Menopause: biology and pathology. New York, NY: Academic Press, 2000: 315-326.